Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Text Size
1 study found for:    "Urachal cancer"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Active, not recruiting Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal Remnant
Conditions: Bladder Cancer;   Urethral Cancer;   Urachal Cancer
Interventions: Drug: 5-Fluorouracil (5-FU);   Drug: Leucovorin;   Drug: Cisplatin;   Drug: Gemcitabine
To Top

† Indicates status has not been verified in more than two years